Target intelligence / Profile preview

Glutamine-rich protein 2 (QRICH2)

Target
QRICH2
Molecular classification
Other
01

Overview

Glutamine-rich protein 2 (QRICH2) is a protein encoded by the QRICH2 gene located on human chromosome 17q25.1[1][5]. QRICH2 is predominantly expressed in the testis and localizes primarily to the nucleus and sperm flagellum, where it plays a crucial role in the formation, structure maintenance, and motility of sperm flagella[1][5][6]. It acts as a suppressor of ubiquitination and degradation of proteins involved in flagellar development[5]. QRICH2 regulates glutamine/glutamate metabolism and participates in maintaining tubulin stability and its post-translational modifications (especially glutamylation), by interacting with α-tubulin and possibly regulating the enzymes involved in these processes[2]. Loss-of-function mutations in QRICH2 lead to male infertility, most notably by causing multiple morphological abnormalities of sperm flagella (MMAF), ultimately resulting in non-motile or malformed sperm[2][3]. There are currently no known drugs targeting QRICH2, and it is not regarded as a therapeutic target such as a receptor, enzyme, transporter, or classical druggable protein[1][5].

Other names
QRICH2glutamine rich 2SPGF35DKFZP434P0316glutamine-rich protein 2
02

Biological functions

Sperm flagellum formation and structure maintenanceNegative regulation of ubiquitin-dependent protein catabolic processAmino acid metabolism (regulating glutamine/glutamate balance)Sperm motilityRegulation of tubulin glutamylation and stabilityCell projection assembly
03

Disease associations

Male infertility (specifically, spermatogenic failure 35 and multiple morphological abnormalities of sperm flagella [MMAF])
04

Biomarkers

Potential biomarker for spermatogenic failure/male infertility associated with sperm flagellar defects

Beyond the preview

Go deeper on Glutamine-rich protein 2 (QRICH2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamine-rich protein 2 (QRICH2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call